Rochester, NY - Researchers are calling for beta-blocker treatment for patients with intermittent claudication, arguing that it is "old school" to avoid them in this high-risk group [1]. The new study ...
The pathophysiology of intermittent claudication is complex as it involves both a reduction in blood flow to peripheral tissues as well as changes in the metabolic function of skeletal muscle, caused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results